Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting

Authors

Philipp Albrecht, Heinrich Heine University Düsseldorf
IK Bjorna
David Brassat, Université de Toulouse III
Rachel Farrell, University College London
Peter Feys, Hasselt University
Jeremy Hobart, Peninsula Medical School
Raymond Hupperts, Zuyderland
Michael Linnebank, Helios Clinic Hagen-Ambrock
J Magdic
Celia Oreja-Guevara, Complutense University
Carlo Pozzilli, University of Rome La Sapienza
Antonio Vasco Salgado, Hospital Fernando Fonseca
Tjalf Ziemssen, Technische Universität Dresden

ORCID

• Jeremy Hobart: 0000-0002-2114-7920

DOI

10.1177/1756286418803248

Publication Date

2018-10-05

Publication Title

Therapeutic Advances in Neurological Disorders

ISSN

1756-2856

Embargo Period

2019-12-07

Recommended Citation

Albrecht, P., Bjorna, I., Brassat, D., Farrell, R., Feys, P., Hobart, J., Hupperts, R., Linnebank, M., Magdic, J., Oreja-Guevara, C., Pozzilli, C., Salgado, A., & Ziemssen, T. (2018) 'Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting', Therapeutic Advances in Neurological Disorders, . Available at: 10.1177/1756286418803248